DK1364642T3 - Præparat til afgivelse af dithranol - Google Patents

Præparat til afgivelse af dithranol

Info

Publication number
DK1364642T3
DK1364642T3 DK03253186T DK03253186T DK1364642T3 DK 1364642 T3 DK1364642 T3 DK 1364642T3 DK 03253186 T DK03253186 T DK 03253186T DK 03253186 T DK03253186 T DK 03253186T DK 1364642 T3 DK1364642 T3 DK 1364642T3
Authority
DK
Denmark
Prior art keywords
dithranol
delivering
preparation
noisome
dermatophytoses
Prior art date
Application number
DK03253186T
Other languages
Danish (da)
English (en)
Inventor
Suresh Kumar Gidwani
Purushottam Sharshi Singnurkar
Original Assignee
Usv Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Usv Ltd filed Critical Usv Ltd
Application granted granted Critical
Publication of DK1364642T3 publication Critical patent/DK1364642T3/da

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/21—Emulsions characterized by droplet sizes below 1 micron
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/413—Nanosized, i.e. having sizes below 100 nm

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Nanotechnology (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK03253186T 2002-05-23 2003-05-21 Præparat til afgivelse af dithranol DK1364642T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38299702P 2002-05-23 2002-05-23
US10/371,295 US20030219465A1 (en) 2002-05-23 2003-02-21 Composition for delivery of dithranol

Publications (1)

Publication Number Publication Date
DK1364642T3 true DK1364642T3 (da) 2006-11-27

Family

ID=29406719

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03253186T DK1364642T3 (da) 2002-05-23 2003-05-21 Præparat til afgivelse af dithranol

Country Status (8)

Country Link
US (1) US20030219465A1 (fr)
EP (1) EP1364642B1 (fr)
JP (1) JP2003342171A (fr)
AT (1) ATE335466T1 (fr)
DE (1) DE60307358T2 (fr)
DK (1) DK1364642T3 (fr)
ES (1) ES2269920T3 (fr)
PT (1) PT1364642E (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1667619A4 (fr) * 2003-09-19 2007-10-10 Drugtech Corp Systeme pharmaceutique d'administration
AU2006225991B2 (en) * 2005-03-21 2010-01-21 Lifecare Innovations Pvt. Ltd. A novel inter and intra multilamellar vesicular composition.
EA200870153A1 (ru) * 2006-01-05 2008-12-30 Драгтек Корпорейшн Композиция и способ ее использования
EP2045320B1 (fr) * 2007-09-19 2012-04-25 Bubbles & Beyond Gmbh Produit de nettoyage pour la suppression de couches de couleurs de surfaces, procédé de fabrication du produit et procédé de nettoyage
MX2013004296A (es) * 2010-10-21 2013-09-26 Cadila Healthcare Ltd Composiciones farmaceuticas topicas que contienen gotas de tamaño nanometrico para el tratamiento de soriasis.
US9789123B2 (en) 2010-10-21 2017-10-17 Cadila Healthcare Limited Topical pharmaceutical compositions containing nanodroplets for the treatment of psoriasis
US8389431B2 (en) * 2011-02-03 2013-03-05 Steag Energy Services Gmbh Method for treating SCR catalysts having accumulated iron compounds
CN103860387B (zh) * 2014-03-06 2016-01-20 东南大学 水杨酸纳米结构脂质载体及其制备方法和应用
EP3182955B1 (fr) 2014-08-20 2019-11-20 Amantin Experts Compositions et procédés pour une humidification et une libération contrôlées de principes actifs

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3819657A (en) * 1972-10-20 1974-06-25 Gen Mills Chem Inc Methylation of tocopherols
US4102995A (en) * 1976-05-13 1978-07-25 Westwood Pharmaceuticals Inc. Tar gel formulation
US4287214A (en) * 1979-09-24 1981-09-01 Scott Eugene J Van Dithranol compositions stabilized with alpha hydroxyacids
US4367224A (en) * 1981-05-13 1983-01-04 Scott Eugene J Van Stable dithranol compositions in anhydrous vehicles
US4551480A (en) * 1983-06-21 1985-11-05 Stiefel Laboratories, Inc. Compositions for the treatment of psoriasis
DE3603859A1 (de) * 1986-02-07 1987-08-13 Roehm Pharma Gmbh Abwaschbare topische zubereitung zur therapie der psoriasis
US4911928A (en) * 1987-03-13 1990-03-27 Micro-Pak, Inc. Paucilamellar lipid vesicles
IL95393A0 (en) * 1989-08-18 1991-06-30 John Morris Co Odor-masked and stabilized compositions for treating keratinous tissue,skin conditions,and promoting wound healing
DE3936328A1 (de) * 1989-10-27 1991-05-02 Schering Ag Pharmazeutische praeparate
JPH06183953A (ja) * 1991-06-24 1994-07-05 Nippon Oil & Fats Co Ltd 混合脂質膜小胞
US5439967A (en) * 1991-09-17 1995-08-08 Micro Vesicular Systems, Inc. Propylene glycol stearate vesicles
US5260065A (en) * 1991-09-17 1993-11-09 Micro Vesicular Systems, Inc. Blended lipid vesicles
FR2681247B1 (fr) * 1991-09-17 1993-12-03 Oreal Composition pharmaceutique pour application topique contenant du dithranol et procede de preparation.
DE69418465T2 (de) * 1993-07-03 1999-12-09 Procter & Gamble Persönliches reinigungsmittel
FR2716110B1 (fr) * 1994-02-16 1996-04-05 Roussel Uclaf Compositions cosmétiques ou pharmaceutiques comprenant des liposomes.
US5476664A (en) * 1994-04-15 1995-12-19 Leonard Bloom Treatment of warts using anthralins and occlusion
DE19519273A1 (de) * 1995-05-22 1996-11-28 Schering Ag Topisch applizierbare Mittel zur Behandlung und Prophylaxe der Alopezie
GB9514878D0 (en) * 1995-07-20 1995-09-20 Danbiosyst Uk Vitamin E as a solubilizer for drugs contained in lipid vehicles
US6068847A (en) * 1996-10-03 2000-05-30 Johnson & Johnson Consumer Products, Inc. Cosmetic compositions
FR2755856B1 (fr) * 1996-11-21 1999-01-29 Merck Clevenot Laboratoires Microcapsules de chitine ou de derives de chitine contenant une substance hydrophobe, notamment un filtre solaire et procede de preparation de telles microcapsules
JPH10265383A (ja) * 1997-03-25 1998-10-06 Takaaki Akaike 医薬組成物
ATE372377T1 (de) * 1998-03-30 2007-09-15 Mibelle Ag Cosmetics Verwendung von nanoemulsionen zur bestimmung der biokompatibilität von lipophilen stoffen im zellkultur-test und dafür geeignete nanoemulsionen
DE19852928C1 (de) * 1998-11-17 2000-08-03 Steffen Panzner Strukturen in Form von Hohlkugeln
AU781703B2 (en) * 1999-01-25 2005-06-09 Blue Ridge Pharmaceuticals, Inc. Liposome formulations
JP2000229815A (ja) * 1999-02-05 2000-08-22 Toshimitsu Hattori リポソームおよびその利用
EP1165141A2 (fr) * 1999-03-31 2002-01-02 Abbott Laboratories Nouvelles formules comprenant des agents de regulation des lipides
RU2264827C2 (ru) * 1999-05-27 2005-11-27 Еуро-Селтик С.А. Препараты для введения противовоспалительных агентов
DE10012151A1 (de) * 2000-03-13 2001-09-27 Gsf Forschungszentrum Umwelt Mittel zur Behandlung von Erkrankungen des Tracheo-Brochialtraktes, insbesondere der COPD

Also Published As

Publication number Publication date
EP1364642A1 (fr) 2003-11-26
DE60307358T2 (de) 2007-08-16
ATE335466T1 (de) 2006-09-15
DE60307358D1 (de) 2006-09-21
US20030219465A1 (en) 2003-11-27
PT1364642E (pt) 2006-11-30
ES2269920T3 (es) 2007-04-01
EP1364642B1 (fr) 2006-08-09
JP2003342171A (ja) 2003-12-03

Similar Documents

Publication Publication Date Title
DK1797053T3 (da) Phenothiazinium-forbindelse til sårheling
ATE106389T1 (de) Neue benzoesäure- und phenylessigsäurederivate, ihre herstellung und verwendung als heilmittel.
ATE216220T1 (de) Osmotische darreichungsform mit zwei mantelschichten
TR200000576T1 (tr) Lipozomal kapsüllenmiş taksan uygulanması için bir yöntem
IT1199967B (it) Liposomi contenenti interleucina,metodo per la loro preparazione e loro uso terapeutico nelle affezioni tumorali
UA88464C2 (ru) Способ дермального введения метадоновой композиции с обеспечением системного действия
ATE410998T1 (de) Verwendung einer proteinkinase a-inaktivierenden verbindung in einer kosmetisch verträglichen zusammensetzung zur aufhellung der haut
NO963239L (no) Klorpyrimid-mellomprodukter
ATE361084T1 (de) Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis
DE3781177D1 (de) Gemischte phosphorsaeurediester, ihre herstellung und verwendung als entzuendungshemmende mittel.
DE69811371T2 (de) Verwendung von substanzen mit oxytocinwirkung zur herstellung von arzneimitteln zur wundheilung
DK1364642T3 (da) Præparat til afgivelse af dithranol
WO2002005782A3 (fr) Sels stables d'acide o-acetylsalicylique avec des acides amines basiques
EP1138323A3 (fr) Resveratrol pour le traitement de l'eczéma exfoliative, de l'acné ou du psoriasis
ATE77230T1 (de) Melatoninhaltige mittel sowie deren verwendungen.
BR9703371A (pt) Injeção direta de oxigênio em produção de ácido nítrico
TR200001486T2 (tr) Hiperkeratozlu deri hastalıklarının tedavisi için diol ve alfa-hidroksi asitten oluşan bir karışımın kullanılması
DE3884309T2 (de) Transdermales Abgabesystem für Procaterol.
ES2141978T3 (es) Retinoides triciclicos, metodos para su produccion y uso.
EP0227531A3 (fr) Esters de l'acide pyroglutamique utilisés commme promoteurs de la pénétration dermique de médicaments
ATE238987T1 (de) Neue vitamin d-derivate mit cyclopropylringen in den seitenketten, verfahren und zwischenprodukte zu ihrer herstellung sowie ihre verwendung zur herstellung von arzneimitteln
DE3675722D1 (de) 4-alkoxy-3-pyrrolin-2-on-1-yl-essigsaeurealkyl- bzw. -benzylester sowie deren herstellung.
DK1115375T3 (da) Anvendelse af mindst ét 10-hydroxy-2-decensyrederivat i et præparat til at fremme hudafstödning
DE69637416D1 (de) Topische anwendung von opioiden, wie morphin, zur linderung von juckreiz und hautkrankheiten sowie hautreizungen
UA70019A (en) Method for treating nasal furuncles